Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWH

Healthcare Medical Devices
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (NDAQ:AWH)

Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results

GlobeNewswire 7 days ago

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®

GlobeNewswire November 7, 2024

Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024

GlobeNewswire November 4, 2024

Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024

GlobeNewswire October 25, 2024

Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health

GlobeNewswire October 23, 2024

Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®

GlobeNewswire October 15, 2024

Aspira Women's Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass

GlobeNewswire September 10, 2024

Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 6, 2024

Aspira Women's Health Selected as a Spoke for the Investor Catalyst Hub

GlobeNewswire September 5, 2024

Aspira Women's Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses

GlobeNewswire August 27, 2024

Aspira Women's Health Reports Second Quarter 2024 Financial Results

GlobeNewswire August 12, 2024

Aspira Women's Health's Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women's Health (NPWH) Women's Healthcare Conference

GlobeNewswire August 5, 2024

Aspira Women's Health Announces Poster Presentation at the Menopause Society's 2024 Annual Meeting

GlobeNewswire August 1, 2024

Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 12

GlobeNewswire July 31, 2024

Aspira Women's Health Appoints Mr. John Ragard to its Board of Directors

GlobeNewswire July 29, 2024

Aspira Women's Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights

GlobeNewswire July 11, 2024

Aspira Women's Health Announces Closing of $1.9 Million Private Placement Equity Financing

GlobeNewswire July 9, 2024

Aspira Women's Health Announces $1.935 Million Private Placement Equity Financing

GlobeNewswire July 1, 2024

Aspira Women's Health Provides Commercial, Reimbursement and Cash Guidance Updates

GlobeNewswire June 13, 2024

Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21

GlobeNewswire May 16, 2024